Gene expression analysis as an aid to the identification of drug targets

Pharmacogenomics

Volumn 1, Issue 4, 2000, Pages 375-384

  Zanders, Edward D ^a,b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b De Novo Pharmaceuticals   (United Kingdom)

Author keywords

cDNA microarray; Cell signalling; mRNA; Transcription

Indexed keywords

ANIMAL; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; METHODOLOGY; PHARMACOGENETICS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION; HUMANS; PHARMACOGENETICS; SIGNAL TRANSDUCTION;

EID: 0034330378     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.1.4.375     Document Type: Review

References (39)

1. DREWS J: Drug discovery: a historical perspective. Science (2000) 287:1960-1964.
2. VUKMIROVIC OG, TILGHMAN SM: Exploring genome space. Nature (2000) 405:820-822. General introduction to the issues of functional genomics.
3. EISENBERG D, MARCOTTE EM, XENARIOS I, YEATES TO: Protein function in the post-genomic era. Nature (2000) 405:823-826. Good introduction to phylogenetic comparisons of protein families and protein networks.
4. LOCKHART DJ, WINZELER EA: Genomics, gene expression and DNA arrays. Nature (2000) 405:827-836. Detailed review of gene expression array technology and data analysis issues.
5. PANDEY A, MANN M: Proteomics to study genes and genomes. Nature (2000) 405:837-846. Review from pioneers of protein mass spectrometry.
6. HUNTER T: Signaling-2000 and beyond. Cell (2000) 100:113-127. Authoritative review of many aspects of cell signalling.
7. DE MARTIN R, SCHMID, JA, HOFER-WARBINEK R: The NF-κB/Rel family of transcription factors in oncogenic transformation and apoptosis. Mutation Res. (1999) 437:231-243. Comprehensive review of important transcription factor family of interest as drug targets.
8. KOPP E, GHOSH S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (1994) 265:956-959.
9. HUNTER T, PLOWMAN GD: The protein kinases of budding yeast: six score and more. Trends. Biochem. Sci. (1997) 22:18-22.
10. PLOWMAN GD, SUDARSANAM S, BINGHAM J, WHYTE D, HUNTER T: The protein kinases of Caenorhabditis elegans: a model for signal transduction in multicellular organisms. Proc. Natl. Acad. Sci. USA (1999) 96:13603-13610.
11. ROEST CROLLIUS H, JAILLON O, BERNOT A et al.: Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence. Nature Genetics (2000) 25:235-238.
12. EWING B, GREEN P: Analysis of expressed sequence tags indicates 35,000 human genes. Nature Genetics (2000) 25:232-234.
13. SCHULTZ J, DOERKS T, PONTING CP, COPLEY RR, BORK P: More than 1,000 putative new human signalling proteins revealed by EST data mining. Nature Genetics (2000) 25:201-204. Application of bioinformatics to identification of putative signalling molecules.
14. CHU S, DERISI J, EISEN M, MULHOLLAND J, BOTSTEIN D, BROWN PO, HERSKOWITZ I: The transcriptional program of sporulation in budding yeast. Science (1998) 282:699-705. Pioneering study of expression of entire yeast genome.
15. SHELTON DN, CHANG E, WHITTIER PS, CHOI D, FUNK WD: Microarray analysis of replicative senescence. Curr. Biol. (1999) 9:939-945.
16. LY DH, LOCKHART DJ, LERNER RA, SCHULTZ PG: Mitotic misregulation and human aging. Science (2000) 287:2486-2492.
17. VOEHRINGER DW, HIRSCHBERG DL, XIAO J et al.: Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc. Natl. Acad. Sci. USA (2000) 97:2680-2685.
18. PHILLIPS RL, ERNST RE, BRUNK B et al.: The genetic program of hematopoietic stem cells. Science (2000) 288:1635-1640.
19. EISEN, MB, SPELLMAN PT, BROWN PO, BOTSTEIN D: Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA (1998) 95:14863-14868.
20. NIEHRS C, POLLET N: Synexpression groups in eukaryotes. Nature (1999) 402:483-487.
21. JENSEN LJ, KNUDSEN S: Automatic discovery of regulatory patterns in promoter regions based on whole cell expression data and functional annotation. Bioinformatics (2000) 16:326-333.
22. D'HAESELEER P, LIANG S, SOMOGYI R: Genetic network inference: from co-expression clustering to reverse engineering. Bioinformatics (2000) (In Press). (See [101] for web pre-print). Description of mathematical tools for extracting information from gene expression experiments.
23. LEWIS AJ, MANNING AM: New targets for anti-inflammatory drugs. Curr. Opin. Chem. Biol. (1999) 3:489-494.
24. POSAS F, TAKEKAWA M, SAITO H: Signal transduction by MAP kinase cascades in budding yeast. Curr. Opin. Microbiol. (1998) 1:175-182.
25. ROBERTS CJ, NELSON B, MARTON MJ: Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science (2000) 287:873-880. Comprehensive study of MAPK signalling pathways in yeast and their influence on large-scale gene expression.
26. MARTON MJ, DERISI JL, BENNETT HA et al.: Drug target validation and identification of secondary drug target effects using cDNA microarrays. Nature Med. (1998) 4:1293-1301. Example of use of microarrays to determine effects of immunosuppressant drugs on yeast target genes.
27. NORMAN TC, SMITH DL, SORGER PK et al.: Genetic selection of peptide inhibitors of biological pathways. Science (1999) 285:591-595.
28. FELDHAUS MJ, LUALHATI M, CARDON K, ROTH B, KAMB A: Oligonucleotide-conjugated beads for transdominant genetic experiments. Nucleic Acids Res. (2000) 28:534-543.
29. IYER VR, EISEN MB, ROSS DT et al.: The transcriptional program in the response of human fibroblasts to serum. Science. (1999) 283:83-87. First detailed study of immediate early gene induction in human cells using microarrays.
30. FAMBROUGH D, MCCLURE K, KAZLAUSKAS A, LANDER ES: Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell. (1999) 97:727-741. Demonstration of the power of gene expression technology coupled with selective pathway mutagenesis.
31. MULLER-LADNER U, GAY RE, GAY S: Activation of synoviocytes. Curr. Opin. Rheumatol. (2000) 12:186-194.
32. BONDESON J, FOXWELL B, BRENNAN F, FELDMANN M: Defining therapeutic targets by using adenovirus: blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc. Natl. Acad. Sci. USA (1999) 96:5668-5673.
33. BAILEY JE: Lessons from metabolic engineering for functional genomics and drug discovery. Nature Biotechnol. (1999) 17:616-618. Useful discussion of drug discovery issues in the 'post-genomic' era.
34. HUANG S: The practical problems of post-genomic biology. Nature Biotechnol. (2000) 18:471-472. As for [31] above.
35. http://ww.cs.unm.edu/∼patrik/ Patrik D'Haeseleer Home Page
36. http://www.stke.org/cgi/content/full/OC_sigtrans;1999/1/ pe1/ WHITMARSH AJ, DAVIS RJ: Signal transduction by MAP kinases: regulation by phosphorylation-dependent switches. Science stke (1999). Good current overview of MAPK.
37. http://www.arcaris.com Arcaris, Inc.
38. http://www.stke.org/cgi/content/full/OC_sigtrans;1999/3/ pe1/ HILL CS, TREISMAN R. Growth factors and gene expression: fresh insights from arrays. Science stke (1999). Detailed discussion of [27,28] with useful commentary.
39. http://genome-www.stanford.edu/serum Data from Iyer et al. [27].